Dementia: Can GLP-1 Drugs Lower Your Risk?
A review in Science suggests glucagon-like peptide-1 (GLP-1) medications may be linked to better brain health. Itβs still unclear whether they act directly on the brain or whether benefits stem from improved cardiometabolic health. Observational studies suggest GLP-1 medications may be associated with a lower risk of cognitive impairment and dementia in people with obesity […]
